{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T05:52:49Z","timestamp":1790401969373,"version":"4.1.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,9,25]],"date-time":"2020-09-25T00:00:00Z","timestamp":1600992000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,9,25]],"date-time":"2020-09-25T00:00:00Z","timestamp":1600992000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"The National Graduate School of Clinical Investigation"},{"DOI":"10.13039\/100007753","name":"It\u00e4-Suomen Yliopisto","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007753","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pregnancy Childbirth"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>The purpose of this study was to determine whether first trimester trisomy screening (FTS) parameters are affected by alcohol and drug use.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>A routine combined FTS including measurements of maternal serum levels of free \u03b2-human chorionic gonadotropin subunit (free \u03b2-hCG) and pregnancy-associated plasma protein A (PAPP-A) were measured at 9\u201311 weeks of gestation, and fetal nuchal translucency thickness (NTT) at 11\u201313 weeks of gestation. In total 544 women with singleton pregnancies [71 alcohol and drug abusers, 88 smokers, 168 non-smokers delivering a small for gestational age (SGA) child, and 217 unexposed control women] were assessed.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>Free \u03b2-hCG levels were higher in alcohol and drug abusing than in unexposed pregnant women [mean 1.5 vs. 1.2 multiples of medians (MoM); <jats:italic>P<\/jats:italic>\u2009=\u20090.013]. However, stepwise multiple linear regression analyses suggested that smoking could explain increased free \u03b2-hCG. Additionally, we observed lower PAPP-A levels in the smoking mothers (0.9 vs. 1.2 MoM; <jats:italic>P<\/jats:italic>\u2009=\u20090.045) and in those giving birth to an SGA child compared to the controls (1.1 vs.. 1.2 MoM; <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001). Fetal NTT did not differ significantly between any of the groups.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>The present study shows increased free \u03b2-hCG levels in alcohol and drug abusers, but maternal smoking may explain the result. Maternal serum PAPP-A levels were lower in smoking than non-smoking mothers, and in mothers delivering an SGA child. However, FTS parameters (PAPP-A, free \u03b2-hCG and NTT) seem not to be applicable for the use as alcohol biomarkers because of their clear overlap between alcohol abusers and healthy controls.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12884-020-03171-9","type":"journal-article","created":{"date-parts":[[2020,9,25]],"date-time":"2020-09-25T11:03:08Z","timestamp":1601031788000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The effect of maternal alcohol and drug abuse on first trimester screening analytes: a retrospective cohort study"],"prefix":"10.1186","volume":"20","author":[{"given":"Anni","family":"Lehikoinen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raimo","family":"Voutilainen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jarkko","family":"Romppanen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seppo","family":"Heinonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,9,25]]},"reference":[{"issue":"1","key":"3171_CR1","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/S0009-9120(02)00424-1","volume":"36","author":"JD Cook","year":"2003","unstructured":"Cook JD. Biochemical markers of alcohol use in pregnant women. Clin Biochem. 2003;36(1):9\u201319.","journal-title":"Clin Biochem"},{"issue":"1","key":"3171_CR2","first-page":"56","volume":"34","author":"LN Bakhireva","year":"2011","unstructured":"Bakhireva LN, Savage DD. Focus on: biomarkers of fetal alcohol exposure and fetal alcohol effects. Alcohol Res Health. 2011;34(1):56\u201363.","journal-title":"Alcohol Res Health"},{"issue":"8","key":"3171_CR3","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1515\/CCLM.2007.190","volume":"45","author":"ML Hannuksela","year":"2007","unstructured":"Hannuksela ML, Liisanantti MK, Nissinen AE, Savolainen MJ. Biochemical markers of alcoholism. Clin Chem Lab Med. 2007;45(8):953\u201361.","journal-title":"Clin Chem Lab Med"},{"issue":"5","key":"3171_CR4","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1179\/acb.2002.048","volume":"57","author":"B Aertgeerts","year":"2002","unstructured":"Aertgeerts B, Buntinx F, Ansoms S, Fevery J. Questionnaires are better than laboratory tests to screen for current alcohol abuse or dependence in a male inpatient population. Acta Clin Belg. 2002;57(5):241\u20139.","journal-title":"Acta Clin Belg"},{"issue":"6","key":"3171_CR5","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1111\/j.1360-0443.1993.tb02093.x","volume":"88","author":"JB Saunders","year":"1993","unstructured":"Saunders JB, Aasland OG, Babor TF, de la Fuente JR, Grant M. Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption\u2013II. Addiction. 1993;88(6):791\u2013804.","journal-title":"Addiction"},{"issue":"3","key":"3171_CR6","first-page":"210","volume":"25","author":"CF Bearer","year":"2001","unstructured":"Bearer CF. Markers to detect drinking during pregnancy. Alcohol Res Health. 2001;25(3):210\u20138.","journal-title":"Alcohol Res Health"},{"issue":"7","key":"3171_CR7","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1111\/acer.13101","volume":"40","author":"S Niemel\u00e4","year":"2016","unstructured":"Niemel\u00e4 S, Niemel\u00e4 O, Ritvanen A, Gissler M, Bloigu A, Werler M, Surcel H. Fetal Alcohol Syndrome and Maternal Alcohol Biomarkers in Sera: A Register-Based Case-Control Study. Alcohol Clin Exp Res. 2016;40(7):1507\u201314.","journal-title":"Alcohol Clin Exp Res."},{"issue":"1","key":"3171_CR8","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1002\/pd.2637","volume":"31","author":"KH Nicolaides","year":"2011","unstructured":"Nicolaides KH. Screening for fetal aneuploidies at 11 to 13 weeks. Prenat Diagn. 2011;31(1):7\u201315.","journal-title":"Prenat Diagn"},{"issue":"5","key":"3171_CR9","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1002\/uog.5332","volume":"31","author":"KO Kagan","year":"2008","unstructured":"Kagan KO, Wright D, Spencer K, Molina FS, Nicolaides KH. First-trimester screening for trisomy 21 by free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A: impact of maternal and pregnancy characteristics. Ultrasound Obstet Gynecol. 2008;31(5):493\u2013502.","journal-title":"Ultrasound Obstet Gynecol"},{"key":"3171_CR10","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1471-2393-8-33","volume":"8","author":"RK Morris","year":"2008","unstructured":"Morris RK, Cnossen JS, Langejans M, Robson SC, Kleijnen J, Ter Riet G, Mol BW, van der Post JA, Khan KS. Serum screening with Down\u2019s syndrome markers to predict pre-eclampsia and small for gestational age: systematic review and meta-analysis. BMC Pregnancy Childbirth. 2008;8:33\u20132393.","journal-title":"BMC Pregnancy Childbirth"},{"key":"3171_CR11","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.placenta.2015.05.011","volume":"36","author":"X Joya","year":"2015","unstructured":"Joya X, Salat-Batlle J, Velezmoro-Jauregui G, Clave S, Garcia-Algar O, Vall O. Prenatal ethanol exposure and placental hCG and IGF2 expression. Placenta. 2015;36:8.","journal-title":"Placenta"},{"issue":"9","key":"3171_CR12","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1002\/pd.2301","volume":"29","author":"GJ Scott","year":"2009","unstructured":"Scott GJ, Holding S, Purcell A, Tutty S, Lindow SW. The influence of maternal opiate use in pregnancy on second trimester biochemical markers for Down syndrome. Prenat Diagn. 2009;29(9):863\u20135.","journal-title":"Prenat Diagn"},{"key":"3171_CR13","volume-title":"Raskauden ajan ultra\u00e4\u00e4nitutkimukset ja seerumiseulonnat rakenne- ja kromosomipoikkeavuuksien tunnistamisessa","author":"I Autti-R\u00e4m\u00f6","year":"2005","unstructured":"Autti-R\u00e4m\u00f6 I, Koskinen H, M\u00e4kel\u00e4 M, Ritvanen A, Taipale P. Raskauden ajan ultra\u00e4\u00e4nitutkimukset ja seerumiseulonnat rakenne- ja kromosomipoikkeavuuksien tunnistamisessa. Saarij\u00e4rvi: Gummerus Kirjapaino Oy; 2005."},{"issue":"4","key":"3171_CR14","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1111\/j.1530-0277.1993.tb00847.x","volume":"17","author":"PI Karl","year":"1993","unstructured":"Karl PI, Fisher SE. Ethanol alters hormone production in cultured human placental trophoblasts. Alcohol Clin Exp Res. 1993;17(4):816\u201321.","journal-title":"Alcohol Clin Exp Res"},{"key":"3171_CR15","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.jpba.2012.01.006","volume":"69","author":"X Joya","year":"2012","unstructured":"Joya X, Friguls B, Ortigosa S, Papaseit E, Martinez SE, Manich A, Garcia-Algar O, Pacifici R, Vall O, Pichini S. Determination of maternal-fetal biomarkers of prenatal exposure to ethanol: a review. J Pharm Biomed Anal. 2012;69:209\u201322.","journal-title":"J Pharm Biomed Anal"},{"issue":"4","key":"3171_CR16","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1542\/peds.2006-0577","volume":"118","author":"SJ Astley","year":"2006","unstructured":"Astley SJ. Comparison of the 4-digit diagnostic code and the Hoyme diagnostic guidelines for fetal alcohol spectrum disorders. Pediatrics. 2006;118(4):1532\u201345.","journal-title":"Pediatrics"},{"issue":"10","key":"3171_CR17","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1007\/s00787-014-0571-6","volume":"23","author":"N Dorrie","year":"2014","unstructured":"Dorrie N, Focker M, Freunscht I, Hebebrand J. Fetal alcohol spectrum disorders. Eur Child Adolesc Psychiatry. 2014;23(10):863\u201375.","journal-title":"Eur Child Adolesc Psychiatry"},{"issue":"3","key":"3171_CR18","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1002\/uog.8808","volume":"37","author":"I Kirkegaard","year":"2011","unstructured":"Kirkegaard I, Henriksen TB, Uldbjerg N. Early fetal growth, PAPP-A and free beta-hCG in relation to risk of delivering a small-for-gestational age infant. Ultrasound Obstet Gynecol. 2011;37(3):341\u20137.","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"2","key":"3171_CR19","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1002\/pd.2671","volume":"31","author":"I Kirkegaard","year":"2011","unstructured":"Kirkegaard I, Henriksen TB, Torring N, Uldbjerg N. PAPP-A and free beta-hCG measured prior to 10 weeks is associated with preterm delivery and small-for-gestational-age infants. Prenat Diagn. 2011;31(2):171\u20135.","journal-title":"Prenat Diagn"},{"issue":"4","key":"3171_CR20","doi-asserted-by":"publisher","first-page":"412.e1","DOI":"10.1016\/j.ajog.2009.07.016","volume":"201","author":"KR Goetzinger","year":"2009","unstructured":"Goetzinger KR, Singla A, Gerkowicz S, Dicke JM, Gray DL, Odibo AO. The efficiency of first-trimester serum analytes and maternal characteristics in predicting fetal growth disorders. Am J Obstet Gynecol. 2009;201(4):412.e1-412.e6.","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"3171_CR21","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1016\/j.ajog.2004.06.052","volume":"191","author":"L Dugoff","year":"2004","unstructured":"Dugoff L, Hobbins JC, Malone FD, Porter TF, Luthy D, Comstock CH, Hankins G, Berkowitz RL, Merkatz I, Craigo SD, Timor-Tritsch IE, Carr SR, Wolfe HM, Vidaver J, D\u2019Alton ME. First-trimester maternal serum PAPP-A and free-beta subunit human chorionic gonadotropin concentrations and nuchal translucency are associated with obstetric complications: a population-based screening study (the FASTER Trial). Am J Obstet Gynecol. 2004;191(4):1446\u201351.","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"3171_CR22","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1016\/j.ajog.2004.05.068","volume":"191","author":"D Krantz","year":"2004","unstructured":"Krantz D, Goetzl L, Simpson JL, Thom E, Zachary J, Hallahan TW, Silver R, Pergament E, Platt LD, Filkins K, Johnson A, Mahoney M, Hogge WA, Wilson RD, Mohide P, Hershey D, Wapner R, First Trimester Maternal Serum Biochemistry and Fetal Nuchal Translucency Screening (BUN) Study Group. Association of extreme first-trimester free human chorionic gonadotropin-beta, pregnancy-associated plasma protein A, and nuchal translucency with intrauterine growth restriction and other adverse pregnancy outcomes. Am J Obstet Gynecol. 2004;191(4):1452\u20138.","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"3171_CR23","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1258\/jms.2008.008049","volume":"15","author":"JP Bestwick","year":"2008","unstructured":"Bestwick JP, Huttly WJ, Wald NJ. First trimester Down\u2019s syndrome screening marker values and cigarette smoking: new data and a meta-analysis on free beta human chorionic gonadotophin, pregnancy-associated plasma protein-A and nuchal translucency. J Med Screen. 2008;15(4):204\u20136.","journal-title":"J Med Screen"},{"issue":"8","key":"3171_CR24","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1055\/s-0032-1331023","volume":"30","author":"I Boucoiran","year":"2013","unstructured":"Boucoiran I, Djemli A, Taillefer C, Rypens F, Delvin E, Audibert F. First-trimester prediction of birth weight. Am J Perinatol. 2013;30(8):665\u201372.","journal-title":"Am J Perinatol"}],"container-title":["BMC Pregnancy and Childbirth"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-020-03171-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12884-020-03171-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-020-03171-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,24]],"date-time":"2021-09-24T23:30:01Z","timestamp":1632526201000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpregnancychildbirth.biomedcentral.com\/articles\/10.1186\/s12884-020-03171-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,25]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["3171"],"URL":"https:\/\/doi.org\/10.1186\/s12884-020-03171-9","relation":{},"ISSN":["1471-2393"],"issn-type":[{"value":"1471-2393","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,25]]},"assertion":[{"value":"2 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Research Ethics Committee of Kuopio University Hospital. All study participants provided an informed written consent.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Consent to publish clinical details of the mothers and babies included in the current study was obtained from the mothers.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The data for the current study are not publicly available due to ethical and legal restrictions. However, upon request, data may be available from Anni Lehikoinen at the Department of Pediatrics, Kuopio University Hospital, Finland.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and materials"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"562"}}